United Kingdom· GB-APID-4106711000001101
Resonium A powder
A medicinal product containing sodium polystyrene sulfonate, registered in United Kingdom by Sanofi.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sodium polystyrene sulfonate
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000283506874
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium polystyrene sulfonate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKionexANI Pharmaceuticals, Inc.
- CanadaJAMP SODIUM POLYSTYRENE SULFONATEJAMP PHARMA CORPORATION
- GermanyAnti-Kalium NaMedice Arzneimittel Pütter Gmbh & Co. Kg
- Japanポリスチレンスルホン酸ナトリウム鳥居薬品
- FrancePOLYSTYRENE SULFONATE DE SODIUM SUBSTIPHARM 454 g, poudre pour suspension orale et rectaleSUBSTIPHARM
- BelgiumKayexalate Sodium 14.99 gSanofi Belgium
- FinlandResoniumSanofi Oy
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Resonium A
- Belgium · Kayexalate Sodium
- Cyprus · Resinsodio
- Germany · Anti-Kalium Na, Elutit®-Natrium-As
- Spain · Resinsodio
- Finland · Resonium
- France · Kayexalate, Lykasty
- Hungary · Resonium
- Italy · Kayexalate
- Luxembourg · Kayexalate Sodium
- Netherlands · Natriumpolystyreensulfonaat Focus, Resonium A
- Poland · Resonium A
- Portugal · Resonium
- Sweden · Resonium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6506efca-4558-4536-895d-938b627c64cc GET /v1/drugs/6506efca-4558-4536-895d-938b627c64cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4106711000001101",
"desc": "Resonium A powder (Sanofi)",
"form": "Powder for oral or rectal suspension",
"vpid": "39712911000001106",
"source": "dmd",
"vtm_id": "13293801000001104",
"strength": "999.34 mg",
"substance": "Sodium polystyrene sulfonate",
"ingredient": "Sodium polystyrene sulfonate",
"supplier_code": "9190711000001101"
}See everything about sodium polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.